Congratulations to Dr Xiao Wan from Professor Eric O’Neill’s group for her success in obtaining an NC3Rs Training Fellowship for ‘Developing human organotypic perfused bioreactors for physiologically reproducible therapeutic compound screening of a tumour microenvironment’. Xiao’s research at the CRUK/MRC Oxford Institute for Radiation Oncology in the Department of Oncology focuses on developing bioreactors that more accurately recapitulate the tumour microenvironm
Congratulations to Dr Bart Cornelissen of the CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology who has secured a £200k grant from UK medical research charity, Pancreatic Cancer Research Fund (PCRF).
Dr James Larkin, a postdoctoral researcher from Nicola Sibson’s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and discuss their work with local MPs.
South Korean and Chinese investors join round into Oxford University spinout developing cancer vaccines.
Oxford Vacmedix UK Limited (OVM), a UK-based biopharma company focused on the development of cancer vaccines, has completed its Series A financing round of $12.5m (£9m) with a consortium of South Korean and Chinese investors.
Congratulations to Professor Eric O'Neill who has been awarded honorary membership of the Royal College of Radiologists (RCR). The award is given in recognition of outstanding contributions to radiation biology, in particular teaching and training.
Associate Professor Peter McHugh of the Department of Oncology has been awarded a 4 year grant from the Medical Research Council.
The news comes hot on the heels of Professor McHugh's Cancer Research UK programme award. Grant success is tough, so this is a truly impressive achievement.
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies.
Cancer therapies such as chemotherapy and radiotherapy aim to kill cancer cells by causing damage to their DNA. However, cancer cells often resist treatment because they have mechanisms in place that allow them to repair their DNA. Understanding how this DNA repair takes place is essential to develop more effective cancer treatments.
Many congratulations to Robert Watson, a NIHR Academic Clinical Fellow in the laboratory of Benjamin Fairfax in the Department of Oncology. Robert was successful in his application for a CRUK pre-doctoral research bursary.
Congratulations to Associate Professor Francesca Buffa who has been awarded a five-year €2M grant by the European Research Council (ERC) to develop computer simulations of cancer cell behaviour, to help us personalise cancer treatment and prevent drug resistance.
This month the MRC Weatherall Institute of Molecular Medicine (WIMM) hosted the annual Regional Breast Cancer Academic Day, an event that brings together breast cancer teams from across the Thames Valley region. This year’s symposium involved the participation of over 70 attendees, including nurses, clinical trial managers, researchers and doctors.